147 results about "Medication use" patented technology

The application discloses a kind of personalized medication service data security processing systems of fusing zero trust architecture and differential privacy, it is related to medical data security technical field, including dynamic trust evaluation to request subject;Inject differential privacy noise;Combining zero trust strategy continues to obtain trust score;Only receive desensitized statistical information or encrypted intermediate representation in the cloud.The application solves the privacy leakage and trust loss problems caused by static protection and weak desensitization in traditional personalized medication services, significantly improves the security, compliance and user trustworthiness of medical data during collection, use and sharing, and provides a secure foundation that can be implemented, verified and continuously evolved for intelligent medication services in high-sensitivity scenarios.

1. Name of the product in this design: Smart Pillbox Clock with LED Display Light. 2. Purpose of this design: It is intended to be placed on a desktop or tabletop to display the time, calendar, and dispense medicines. It also serves as a medicine storage and management tool, providing reminders through visual and acoustic signals. The device can be set to remind users of medications and follow-up appointment dates via light, sound, and vibration. It can store medicines for a seven-day supply. 3. The key design feature of this product is its shape. 4. The image or photograph that best illustrates the design's key points: 3D view 1.

This application relates to the field of smart medical technology and discloses a method and system for monitoring medication adherence in patients during ovulation induction cycles. This invention significantly improves the accuracy and reliability of ovulation induction medication adherence assessment in complex home environments by deeply integrating the real physical boundaries of the human body, the mechanical rigidity constraints of instruments, and the fluid dynamics laws of porous media into a visual monitoring framework. Specifically, this application utilizes dynamic pixel physical mapping and biomechanical filtering technology to effectively eliminate the interference of lens distortion and physiological tremors, reconstructing a pure kinematic sequence. By using a finite state machine with dual boundaries of force application and limit, it accurately identifies and coherently processes the mid-process pauses caused by patients' fear of pain, completely solving the defect of traditional algorithms that are prone to logical breaks.

The utility model discloses a pharmacy is with medicine dispenser, is used for carrying out slitting to medicine piece, include: first board body, second board body, first storage groove and second storage groove, first storage groove sets up on first board body, second storage groove sets up on second board body, first board body has first wall, second board body has second wall, when first board body and second board body adaptation abut, first wall and second wall fit and can be in first storage groove and second storage groove together and fit out the wedge -shaped groove of adaptation storage medicine piece, when first board body and second board body separate, wedge -shaped groove restores first storage groove and second storage groove and makes medicine piece divide into first piece body and second piece body. The utility model can ensure that medicine piece can be accurately divided into even two, effectively avoid the dosage error caused by uneven slitting, guarantee patient medicine safety.

This invention relates to the application of mitochondrial extracts in reversing drug resistance in solid tumors. By combining mitochondrial extracts with chemotherapeutic drugs, the resistance of chemotherapeutic-resistant solid tumors to these drugs can be reversed. Compared to using mitochondrial extracts and chemotherapeutic drugs alone, this method effectively enhances drug efficacy, thereby overcoming chemotherapeutic resistance in solid tumors. This invention, through intervention with mitochondrial extracts in different chemotherapeutic-resistant solid tumor cell lines, has verified that the combined use of mitochondrial transplantation and chemotherapeutic drugs can reverse chemotherapeutic resistance, thereby improving the efficacy of chemotherapy and opening up the possibility of continued treatment for patients with advanced solid tumors who are resistant to chemotherapeutic drugs.

This invention discloses an intelligent health education method, device, equipment, and storage medium for gynecological tumor patients. The method acquires the patient's electronic medical record information and patient interaction data. Based on the electronic medical record information, it identifies the gynecological tumor disease type and treatment stage tags. Based on the patient interaction data, it specifically identifies psychological stress signals related to gynecological tumor treatment, generating a profile of the patient's current psychosomatic state. It matches and dynamically generates personalized health education content and psychological counseling plans from a structured knowledge base. Based on the patient's treatment data, it automatically generates reminders for medication and follow-up examinations. It structurally correlates the output records of personalized health education content and the patient's feedback data on the reminders to form a digital pathmap for patient education. This enables dynamic matching and personalized generation of health education content and psychological counseling plans, improving the patient's cognitive adaptability to health information and the effectiveness of psychological support, achieving closed-loop management throughout the entire hospital and inpatient cycle.

In particular, this disclosure provides technologies, including I-66 formulations, compositions, and methods, for treating various cancers. This disclosure provides technologies, such as formulations, dosages, and drug regimens, for treating conditions, disorders, or diseases, in particular certain types of cancer. In some embodiments, this disclosure provides high-purity I-66 active pharmaceutical ingredients. In some embodiments, this disclosure provides I-66 pharmaceutical products. In some embodiments, this disclosure provides I-66 formulations, which are liquid compositions in which I-66 has sufficiently high solubility and stability for clinical application.

The present application relates to the technical field of artificial intelligence, and particularly relates to an individualized medication prediction method based on artificial intelligence, comprising: acquiring a plurality of standard historical medical data sets; acquiring metabolic capacity scores and drug metabolism rates corresponding to all data groups; training to obtain relationship models corresponding to all standard historical medical data sets; acquiring liver metabolism parameters, gene expression parameters and each drug name in a treatment scheme of a patient to obtain a drug metabolism rate; and determining a corresponding prediction drug amount determination method according to whether the drug types in the treatment scheme have a competitive relationship. The present application integrates drug metabolism enzyme-related gene expression and liver metabolism function, simultaneously incorporates drug absorption competition and metabolism enzyme competition when drugs are used in combination, corrects the final output prediction drug amount when drugs are used in combination, so that the model is more suitable for the actual drug use scene, and the accuracy of the prediction result is increased.

We provide the system. [Solution] A means of acquiring voice input and converting it into text data, A processing means that analyzes text data to identify user requests, A means for generating appropriate information based on a request and providing it to the user through an information generation means, Means having a function to perform operations on an information processing device when remote operation is permitted, To support the elderly, we provide a voice interface and a means to assist them in checking medication information and schedules. A system that includes this.

The application relates to the technical field of medical health data processing, and discloses a blood potassium management and monitoring method and system based on multivariate input, which comprises the following steps: firstly, obtaining demographic data, medical history data, test data, medication data and medication adjustment event data of a patient, and performing pretreatment; then, based on the pretreated data, determining whether to enter a potassium supplement path or a potassium reduction path, and performing risk stratification on the blood potassium state of the patient, and outputting a risk stratification result and a treatment strategy; then, according to the determined path and the risk stratification result, performing corresponding medication decision to generate a medication adjustment scheme, and based on the medication adjustment scheme, generating a review suggestion for the patient; finally, showing the analysis result containing the risk stratification result, the treatment strategy, the medication adjustment scheme and the review suggestion to a user end, and recording an operation log. The application meets the clinical demand for fine, individualized and whole-process management of blood potassium.

The application discloses a medicine patch with gradient effect on human body, which comprises, from outside to inside, a back layer, a heating layer and a solid medicine layer, wherein the solid medicine layer is provided with solid medicine A; and further comprises a medicine liquid cavity for sealing liquid medicine B; when used, the medicine patch is attached to the human body for a set time, the medicine liquid cavity can be opened and the liquid medicine B can flow into the solid medicine layer; the solid medicine A can preliminarily treat related diseases under the action of heating, and the liquid medicine B is added in a progressive manner after the set time; the medicine patch has the gradient treatment requirement and the treatment effect, and can further drive the residual effect of the solid medicine B to continuously act on the affected area, improve the utilization rate of the medicine, and make the treatment medicine more targeted; thus, the traditional inertial thinking of the medicine patch is changed, interval medicine for treatment is made possible, the medicine effect is improved, and the foundation for the final treatment effect is laid.

The application belongs to the technical field of biological medicine, and particularly relates to a freeze-dried preparation based on synergistic effect of trehalose and arginine for optimizing the performance of omalizumab reconstitution and a preparation method thereof. The preparation method comprises the following steps: preparing a histidine-hydrochloric acid buffer, dissolving omalizumab, trehalose, arginine and polysorbate 20 in the histidine-hydrochloric acid buffer to prepare a solution preparation; and freeze-drying the solution preparation to obtain the freeze-dried preparation; wherein the molar concentration ratio of trehalose to arginine in the solution preparation is 10-90:15-55. The freeze-dried preparation obtained by using the preparation method has a fast reconstitution speed and a fast bubble disappearance speed during reconstitution, can save time, meets the clinical emergency drug demand, and is more convenient to use.

The application relates to an AI medical, nursing, health care and medicine management service system and a method thereof, and relates to the technical field of intelligent medical equipment and health management. The system comprises an intelligent terminal and a cloud data platform. The intelligent terminal is provided with a plurality of physically isolated and electrically independent intelligent medicine storage units. Each unit is provided with a lock control mechanism, a state indication component and a medicine taking sensing sensor. A master control unit sends an unlocking instruction at a preset medicine taking time and triggers an audible and light reminder. After an effective medicine taking signal is acquired through the medicine taking sensing sensor, behavior data containing a time stamp are generated and uploaded to the cloud, thereby forming a medicine taking behavior closed loop management mechanism. The application can realize forced verification and recording of medicine taking behavior, break the association link between health monitoring data and medicine taking records, and build a full-process family health management closed loop from reminding to replenishment.

The invention relates to a patient decision support system and operating method based on self-care algorithms that evaluate patient activity for patients diagnosed with liver cirrhosis, which is intended to monitor and manage patients' health conditions, provides regular data tracking and personalised recommendations, tracks patients' daily and weekly activities, medication use, diet, and exercise routines, collects and evaluates the data, and presents user-specific recommendations, and which uses artificial intelligence and care algorithms to determine, on the basis of the patient's health data, which treatment and care pathways are the most appropriate.

This invention proposes an intelligent menopausal patient health management platform, comprising a doctor-patient interaction unit, an information processing unit, a pharmaceutical service unit, and a medical terminal. The doctor-patient interaction unit allows patients to conveniently fill in initial diagnosis information, including questionnaire data and medication information, on a mobile terminal, achieving effective collection of information from outside the hospital. The information processing unit can perform structured processing of this information. Based on risk assessment results and medication information, the pharmaceutical service unit can intelligently generate a pharmaceutical service plan including medication rescheduling suggestions, individualized medication guidance, and follow-up reminders. This not only improves the accuracy and safety of medication use but also enhances patient medication adherence through continuous follow-up reminders. The medical terminal provides medical staff with an integrated view of patient information, enabling them to comprehensively understand the patient's initial diagnosis information, system-generated risk assessment results, and pharmaceutical recommendations, and efficiently respond to complex patient questions.

The invention relates to a system and a method comprising a medicine chamber, which provide warnings both from a digital display located on the cap of the bottle and from a mobile application, by adding medication reminders through the mobile application in accordance with said reminders. The invention particularly relates to an Internet of Things (loT) based medication reminder water bottle system and method comprising a water bottle, a cap, a medicine chamber, and a server, an interface, and a database located on a mobile platform.

The present application relates to the field of medical informatics, and provides a paliperidone efficacy prediction method and system based on plasma metabolomics. The method comprises the following steps: collecting basic data of a target patient; performing feature selection on metabolites through the basic data to obtain relevant metabolites corresponding to paliperidone efficacy; training a neural network based on the relevant metabolites and baseline data in the basic data to obtain a prediction model; and performing paliperidone efficacy prediction on a patient to be predicted through the prediction model to obtain a prediction result. The present application can predict the probability of patient response to paliperidone, thereby more accurately evaluating the efficacy of paliperidone before medication, and providing an auxiliary decision for individualized medication.

This invention belongs to the pharmaceutical field, specifically relating to a sodium nitroprusside injection and its preparation method. The sodium nitroprusside injection comprises the following raw materials in parts by weight: 1.5–3.5 parts sodium nitroprusside and 100 parts water for injection. This invention solves the problem of poor stability of sodium nitroprusside aqueous solutions by optimizing the formulation and preparation process without introducing other excipients. The sodium nitroprusside injection prepared by this invention is a sterile injectable preparation manufactured using modern aseptic filling technology combined with non-terminal sterilization. It not only has the advantages of direct and rapid action and high sterility assurance, but also has few adverse reactions and can be transported and stored at room temperature, thus improving the stability and safety of the product. This invention also provides its preparation method, which is simple, safe to use, and has stable quality.

The application provides application of serum sIL-2R as an ADAM10 inhibitor companion diagnostic marker and a corresponding kit, including two core application scenarios: before treatment, screening of a patient population with high activity of an ADAM10-sIL-2R pathway and most likely to benefit from ADAM10 inhibitor treatment by detecting the serum sIL-2R level of the patient; during and after treatment, evaluating the inhibition effect of the ADAM10 inhibitor on the target pathway and the treatment efficacy by dynamically monitoring the change of the serum sIL-2R level; the liquid companion diagnostic strategy will provide an indispensable supporting tool for the precise application of the ADAM10 inhibitor in pancreatic cancer, and significantly improve the precision and effectiveness of clinical medication.

This utility model relates to a therapeutic patch for liver, gallbladder, pancreas, and spleen care, belonging to the technical field of therapeutic patches. Its key technical features include: a temperature control structure and a patch body. The temperature control structure is movably positioned on top of the patch body. The patch body includes a substrate layer and a drug-releasing layer. The temperature control structure is located on top of the substrate layer, and the drug-releasing layer is located at the bottom of the substrate layer. Several drug placement slots are pressed onto the sidewall of the drug-releasing layer away from the substrate layer. The temperature control structure includes a piece of absorbent cotton cloth and Velcro. The Velcro is located on the back of the absorbent cotton cloth and adhered to the top of the substrate layer. A heating pad is placed between the absorbent cotton cloth and the substrate layer. The outer surface of the drug-releasing layer is coated with acrylic adhesive. The drug placement slots are arranged in a rectangular array. This utility model has a simple structure, is easy to use, and has good heat therapy and drug-releasing function. It can be used for local treatment of the liver, gallbladder, pancreas, and spleen areas, and has high comfort and clinical applicability.

This paper provides a system and method for selecting weight-loss medications using machine learning models to address obesity. [Solution] System 100 receives physiological measurements from the user and applies the measurements to a machine learning model. The machine learning model can be trained using multiple examples, each example including sample physiological measurements from a sample user and a corresponding sample weight-loss drug administered to the sample user. The system also generates metrics indicating expected outcomes associated with the user's weight-loss drug based on the application of one or more physiological measurements to the machine learning model, and sends a message indicating the expected outcomes associated with the weight-loss drug to the user's associated user device. [Effects] It can improve the effectiveness of weight-loss drugs when dealing with obesity.

The application discloses a medication compliance monitoring and reminding platform for chronic disease patients in a large internal medicine department, and belongs to the technical field of medical intelligent monitoring. The platform comprises 10 modules in cooperation and linkage, adopts a distributed architecture for deployment, collects full-amount data related to patient medication through a multi-source data acquisition module, and transmits the data to a core operation and analysis module after processing by a special noise reduction formula. The core operation and analysis module realizes precise compliance evaluation, medication trend prediction and reminding strategy optimization based on multiple special mathematical formulas. An intelligent reminding module provides individualized and hierarchical reminding. A medical staff end management module realizes patient whole-process management and intervention scheme formulation. A data storage and encryption module ensures data security. A compliance intervention module realizes precise intervention and effect tracking. An abnormality early warning module realizes real-time early warning and linkage disposal. A cross-terminal synchronization module and a system self-checking and calibration module ensure stable operation of the system and data synchronization.

The utility model discloses a double -deck urethral support with medicine carrier, including metal support, both ends of metal support are reverse coiling setting, metal support includes inner layer and outer layer, the fixed connection through multiple connecting keys between inner layer and outer layer, be provided with the medicine storage bag in the inner layer, the fixed connection through multiple dissolving keys between medicine storage bag and inner layer, the utility model discloses can increase the support of support, improve the use efficiency of medicine, reduce side effect, and the use effect is better after urethral support installation, and can be to urethral damaged tissue automatic medicine, accelerate the repair of urethra inner wall damaged tissue.

The utility model discloses a kind of medicine applying devices for gynaecology vaginitis, belong to gynaecology medical instrument technical field, a kind of medicine applying device for gynaecology vaginitis, including push plate, push plate front end is fixedly connected with medicine applying structure, medicine applying structure inside is threadedly connected with injection structure, push plate rear end is fixedly connected with limit ring, push plate inner surface and limit ring inner surface are threadedly connected with push structure, it is cooperated by medicine applying structure and push structure, when gynaecology doctor treats vaginitis patient, capsule, tablet and powder drug can be quickly sent into patient vagina, complete medicine applying, by injection structure and medicine applying structure and push structure cooperation, so that device can also complete liquid medicine applying, eliminate limitation, by push structure, so that the controllability of device is higher, can effectively avoid to cause harm to the inside of patient's vagina, can realize the function of convenient liquid medicine and high operating precision, improve the practicality of device.

The utility model relates to medicine box technical field discloses a kind of foldable medicine box, including multiple small medicine boxes, the top of each small medicine box is equipped with closure lid, the four sides of each small medicine box are equipped with the connecting assembly for rotationally connecting adjacent small medicine box, the side of each connecting assembly is equipped with the temporary storage connecting assembly's temporary storage assembly, the connecting assembly includes the connecting rod of being set at small medicine box side;By setting foldable multiple small medicine boxes and connecting assembly, temporary storage assembly, the flexible adjustment of medicine box volume is realized;When more medicine needs to be carried, multiple small medicine boxes can be unfolded and connected by connecting assembly, and different medicines are stored separately;When a small amount of medicine is carried or idle, small medicine boxes can be folded together, reducing space occupation and improving portability;At the same time, clear classification structure can reduce the risk of missed or mistaken administration, meet the medication needs of different users in different scenarios.

The present application relates to the precise treatment of kidney disease and the detection technology of intestinal micro-ecological biomarkers, in particular to a biomarker for rapidly screening kidney disease patients treated by leflunomide and application thereof.The present application provides a biomarker for rapidly screening kidney disease patients treated by leflunomide, which can accurately identify whether the patient is an IgAN patient after leflunomide treatment, so as to guide the subsequent medication of the IgAN patient.The results of the specific embodiment of the present application prove that the area under the curve is 0.903, the specificity is 0.83, and the sensitivity is 0.86.

The present application relates to the technical field of medicine dispenser, and particularly relates to a medicine protection device for medicine dispenser, which comprises a protection shell and a storage box slidingly arranged in the protection shell, the storage box is divided into multiple independent storage cavities by a partition plate, a filter screen is arranged at the bottom of each storage cavity, a cavity is formed in the protection shell for collecting medicine debris falling from the filter screen, and a debris cleaning mechanism is further arranged in the protection shell, the debris cleaning mechanism is driven by a toothed plate fixedly arranged at one side of the storage box, when the storage box slides in the protection shell, the toothed plate drives the debris cleaning mechanism to operate, and meanwhile, intermittent knocking actions on the filter screen are triggered. The present application realizes instant removal of medicine debris after tablet cutting and multiple medicine separation and storage without external energy source through the mechanical self-cleaning structure driven by the sliding of the storage box and the design of multiple-cavity independent sealing storage, effectively prevents cross contamination, variety confusion and dose misalignment, and significantly improves the safety and accuracy of home medicine.

The application discloses a kind of clinical drug abnormal use identification method based on artificial intelligence, comprising the following steps: obtaining target patient information, and data preprocessing is generated medication event sequence;According to medication event sequence, and extract one-hop neighborhood local subgraph as egonet;Risk weighted egonet structure features are calculated;According to hierarchical priority rule, medication event is layered, and the power law baseline parameter corresponding to each layer is obtained;Using OddBall graph anomaly detection, the power law deviation degree of each time window is calculated and forms deviation degree sequence;Variable point detection is carried out to deviation degree sequence to determine abnormal interval, and output abnormal use identification result;In abnormal interval, edge removal contribution evaluation is carried out to egonet edge set, and determines key drug pair and is associated with abnormal use identification result and outputs.The application improves the accuracy and reviewability of clinical drug abnormal use early warning.

It provides a simple and self-contained medication management system that ensures medication is taken as prescribed and prevents missed doses by utilizing built-in reminders and medication verification functions, without relying on external servers or devices. The present invention provides a medication management system having the following configuration: a pocket (4) arranged in 4 rows and 7 columns on the surface of a main body (1), an LED (3) for notifying the scheduled medication, a liquid crystal display (LCD) (6), a confirmation button (5) for confirming medication, a buzzer (2) for voice notification, an SD card reader (7) for storing data, and an RTC module (12) for time management. In addition, a control and communication module is built-in, enabling the management of medication schedules and the transmission of notifications via the Internet. By doing so, a simple and practical system that supports patient compliance with medication is realized.